Cardiologists discuss the questions and concerns swirling around the thriving wearables market as patients strap on a variety of smart devices and expect their physicians to catch up.

Black children, as well as Hispanic kids and other ethnic minorities, are less likely to receive bystander CPR during an out-of-hospital cardiac arrest (OHCA) than their white counterparts, according to a Journal of the American Heart Association study published July 10.

Boston Scientific’s Watchman device, an alternative to blood thinners in atrial fibrillation patients unable to take medications like warfarin, has for years been touted as a safe, effective therapy to reduce patients’ stroke risk.

Research published in Circulation: Cardiovascular Quality and Outcomes July 9 suggests the public health burden of pulseless in-hospital cardiac arrests is around 38% higher in adults and 18% higher in children than was previously believed.

Multivitamins and the bulk of nutritional supplements do little to protect heart health, in some cases increasing a person’s risk for CV events, an analysis published in the Annals of Internal Medicine has found.

Biotronik on July 8 announced its BIOMONITOR III injectable cardiac monitor, a diagnostic tool designed to document suspected arrhythmias, has been cleared by the FDA.

A large-scale study of people living with HIV has linked the immune deficiency to an increased risk of CVD, in particular heart failure and stroke.

Heart patients of a lower socioeconomic status are far more likely to participate in cardiac rehabilitation if they receive financial incentives to attend sessions, according to a study published in the July 1 edition of JACC: Heart Failure.